Growth Factor News and Research

RSS

Commonly prescribed anti-depressant may halt the growth of childhood sarcoma

A new study has found that a commonly prescribed anti-depressant may halt growth of a type of cancer known as childhood sarcoma, at least in mice and laboratory cell experiments.

6 Nov 2020

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Breast cancer is the leading cause of cancer-related death among the female population globally, despite the ever-growing technology of early detection.

From Bruker BioSpin Group 30 Oct 2020

Novel mechanism increases arterial diameter, allows increased inflow

Upon a heart infarct or stroke, rapid restoration of blood flow, and oxygen delivery to the hypoperfused regions is of eminent importance to prevent further damage to the heart or brain. Arterial diameter is a critical determinant of blood flow conductance.

28 Oct 2020

Scripps Research scientists uncover potential new strategy for treating eye diseases

Scientists at Scripps Research have uncovered a potential new strategy for treating eye diseases that affect millions of people around the world, often resulting in blindness.

27 Oct 2020

Advancements in research on cancer signal transduction and treatment

Cancer is driven by numerous genetic and epigenetic changes occurring at the cellular level. These changes drive normal cells to proliferate and escape processes that usually regulate their survival and migration.

27 Oct 2020

Novel machine learning algorithm helps find drug binding sites

Scientists from the iMolecule group at Skoltech Center for Computational and Data-Intensive Science and Engineering developed BiteNet, a machine learning algorithm that helps find drug binding sites, i.e. potential drug targets, in proteins.

27 Oct 2020

Happiness neurotransmitter serotonin plays role in evolutionary expansion of the neocortex

During human evolution, the size of the brain increased, especially in a particular part called the neocortex.

23 Oct 2020

New therapeutic approach for treating patients with compromised immune systems

A young woman who had been hospitalized for three months straight due to debilitating, recurrent infections with no apparent underlying cause was finally able to go home thanks to a Massachusetts General Hospital (MGH) team who put their heads together, discovered a root of the problem, and developed a novel treatment strategy just for her.

23 Oct 2020

Researchers assess molecular basis of SARS-CoV-2 severity and poor outcomes in lung disease

A recent study published on the preprint server bioRxiv in October 2020 shows that in patients with chronic lung disease, the pattern of gene expression in the different types of cell changes such that the lung epithelium is prepared to tackle SARS-CoV-2 infection. Also, the altered gene programs have an impact on the immune response.

22 Oct 2020

New diagnostic method may allow for real-time detection of cancer growth patterns

Using a 2 ml blood sample from 100 gastric cancer patients, researchers succeeded in identifying cancer cells circulating in the bloodstream and trace them back to their origin tumor by detecting an overexpression of fibroblast growth factor receptor (FGFR2) in both the cancer cells and the tumor.

21 Oct 2020

New tool can provide non-invasive decision support for NSCLC treatment

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

16 Oct 2020

Small molecule restores normal heart development in animal model with rare genetic disorder

A research team at the Greenwood Genetic Center has successfully used small molecules to restore normal heart and valve development in an animal model for Mucolipidosis II (ML II), a rare genetic disorder. Progressive heart disease is commonly associated with ML II.

15 Oct 2020

Study provides new insight into unknown effects of factors that regulate blood vessel formation

A new study by researchers at the University of Eastern Finland provides novel insight into the previously unknown effects of factors regulating blood vessel formation.

14 Oct 2020

SARS-CoV-2 spike protein may induce analgesia

A recent study published in the journal Pain in October 2020 adds another piece to the puzzle, showing that the virus is capable of dulling pain pathways. This may contribute to its early and extensive spread.

7 Oct 2020

Potential drug treatment for AXL-low expressing EGFR-mutated lung cancer

Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.

5 Oct 2020

Study reveals how immune cells sacrifice themselves to help fight off infections

Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection.

1 Oct 2020

Scientists identify key molecules that mediate radioresistance in aggressive brain cancer

Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.

30 Sep 2020

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.

29 Sep 2020

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome.

28 Sep 2020

Study: R-spondin growth factor reduces intestinal tumors in early phase of colorectal cancer

Colorectal cancer constitute the third most common cancer in the Western world. Their incidence constantly increases as the population ages, and despite recent advances in colorectal cancer therapy, the cancer metastasizes in every third of colorectal cancer patients, and a significant part of these patients eventually die from the disease

24 Sep 2020

Growth Factor News and Research

Commonly prescribed anti-depressant may halt the growth of childhood sarcoma

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Novel mechanism increases arterial diameter, allows increased inflow

Scripps Research scientists uncover potential new strategy for treating eye diseases

Advancements in research on cancer signal transduction and treatment

Novel machine learning algorithm helps find drug binding sites

Happiness neurotransmitter serotonin plays role in evolutionary expansion of the neocortex

New therapeutic approach for treating patients with compromised immune systems

Researchers assess molecular basis of SARS-CoV-2 severity and poor outcomes in lung disease

New diagnostic method may allow for real-time detection of cancer growth patterns

New tool can provide non-invasive decision support for NSCLC treatment

Small molecule restores normal heart development in animal model with rare genetic disorder

Study provides new insight into unknown effects of factors that regulate blood vessel formation

SARS-CoV-2 spike protein may induce analgesia

Potential drug treatment for AXL-low expressing EGFR-mutated lung cancer

Study reveals how immune cells sacrifice themselves to help fight off infections

Scientists identify key molecules that mediate radioresistance in aggressive brain cancer

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

Study: R-spondin growth factor reduces intestinal tumors in early phase of colorectal cancer

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News